Isosorbide dinitrate and Niacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide dinitrate (isosorbide dinitrate) and Niacin (niacin). Common drug interactions include benign renal neoplasm among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide dinitrate and Niacin. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Niacin?

Niacin has active ingredients of niacin. It is often used in high blood cholesterol. eHealthMe is studying from 9,009 Niacin users. Check the latest studies of Niacin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

65 people who take Isosorbide dinitrate and Niacin together, and have interactions are studied.

Isosorbide dinitrate and Niacin drug interactions.

What are the common drug interactions of Isosorbide Dinitrate and Niacin, by gender? *:

female:

  1. Benign renal neoplasm (benign (non-cancerous) tumours of the kidney)
  2. Bladder disorder
  3. Blood creatine phosphokinase mm increased
  4. Blood creatinine increased
  5. Blood homocysteine
  6. Blood urea increased
  7. Blood urine present
  8. Bradycardia (abnormally slow heart action)
  9. Breast mass
  10. Carotid artery occlusion (artery blockage)

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Dehydration (dryness resulting from the removal of water)
  3. Cardiomegaly (increased size of heart than normal)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Decreased interest
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Impaired healing
  8. Intermittent claudication
  9. Pain in extremity
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

What are the common drug interactions of Isosorbide Dinitrate and Niacin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Hepatic enzyme increased

50-59:

  1. Anaemia (lack of blood)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Thrombocytopenia (decrease of platelets in blood)

60+:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Haemoglobin decreased
  4. Abdominal pain
  5. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  6. Cystitis (inflammation of the wall of the bladder)
  7. Decreased interest
  8. Impaired healing
  9. Intermittent claudication
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 12.31%
  2. Type 2 Diabetes: 7 people, 10.77%
  3. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 10.77%
  4. Cardiac Disorder: 6 people, 9.23%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 7.69%
  6. Stable Angina (a constant chest pain): 4 people, 6.15%
  7. High Blood Pressure: 4 people, 6.15%
  8. Diabetes: 4 people, 6.15%
  9. Cardiac Failure Congestive: 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and Niacin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide dinitrate and Niacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Niacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Niacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and niacin (the active ingredients of Isosorbide dinitrate and Niacin, respectively), and Isosorbide dinitrate and Niacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: